ClinicalTrials.gg
RecruitingNCT05647135ACCUMULATEUpdated Jul 22, 2024

ImpACt of Very High Protein Content Enteral nUtrition Formulas on Critically Ill MUltipLe trAuma paTiEnts

An observational study in Metabolism, Trauma and Nutritional Deficiency, sponsored by Romanian Society for Enteral and Parenteral Nutrition. Recruiting at 1 site in Romania. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-22.

Primary conditionMultiple TraumaRegistry: Wounds and InjuriesReclassifiedWhy we changed it
Registry
Wounds and Injuries — the first condition term the registry derived for this study.
ClinicalTrials.gg
Multiple Trauma
Why
  1. The study's title name Multiple Trauma, a narrower term within Wounds and Injuries.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Romanian Society for Enteral and Parenteral Nutrition · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
70
Ages
18 Years and older
Sex
All
01

Study summary

This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.

  • Differences regarding achieving protein and calorie daily targets when using enteral nutrition formulas with different protein content
  • Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content
  • Differences regarding body composition when using enteral nutrition formulas with different protein content
Read the detailed description

ImpACt of very high protein Content enteral nUtrition formulas on protein metabolism and residual gastric volume in critically ill MUltipLe trAuma paTiEnts

  • ACCUMULATE trial -

Background and rationale:

Despite an increased survival among critically ill patients, many of the ICU "survivors" may develop prolonged functional disabilities. It has already been proven that nutritional therapy is essential, considering that an adequate provision of calories and proteins may influence patients prognostic.

Multiple trauma patients are on a particular nutritional risk, since their high nitrogen demands and associated nutritional therapy challenges, caused by repeated surgical intervention or multiple imagistic procedures. Although nutritional therapy impact on mortality is still in debate, clear, positive results were obtained in decreasing ICU and hospital stay after adequate nutritional support.

According to ESPEN guideline on clinical nutrition in the ICU early enteral nutrition (within 48 h) should be initiated in order to assure an adequate calorie and protein intake. Beside optimal timing, the management of nutrition therapy in critically ill patients should also integrate the optimal route and caloric/protein targets.

Energy requirements monitoring through indirect calorimetry has been proposed as a standard-of-care method for critically ill patients, considering its proven superiority towards predictive equation.

Beyond calorie intake, proteins proved to play a central role in maintain lean body mass, healing wounds and supporting immune function.For multiple trauma patients it was reported that protein losses may reach 14 % of the total body stores, thus this type of patients are exposed to a particular increased risk of protein deficits. If calorie administration benefits from a proper monitoring tool, protein requirements are still based on predictive equation. The impact of protein administration is also lacking of direct measurements techniques. Lean body mass evaluation by ultrasound and computerized tomography has been reported to have a good correlation with hospital stay and pots-ICU functional capacity. Moreover muscle function evaluation through a hand-grip dynamometer was also tested with good results in patients with ARDS.

Source of administered protein may also influence nitrogen balance, considering that whey proteins (rich in leucine) promote a slower hydrolysis and allow a longer period for absorption.

Reaching the recommended goals is often impeded by gastric intolerance manifested through increased gastric volume residues. It has been already demonstrated that large gastric volume residues are associated with impaired absorption and an increased incidence of aspiration pneumonia.

Gastrointestinal dysfunction in multiple trauma patients admitted to the intensive care unit (ICU) is an important yet underrecognized consequence. There are various causes of gastrointestinal tract dysfunction mostly related to patients general health condition and to their diagnostics. Gastrointestinal failure may be induced by several factors like immunological, biological and mechanical barrier disruption and it may be manifested through stress ulceration, bacterial translocation, ileus, intra-abdominal hypertension, diarrhoea and constipation.

Whether residual gastric volume monitoring should be regularly performed has been extensively discussed. Although the results from some randomised trials which focused on monitoring gastric residual volume, did not find any difference in outcomes, this measurement was far for being abandoned. Moreover, gastric residual volume monitoring is still an essential component of enteral nutrition patient care.

Although several monitoring methods for gastric volume residue measurements were described, there is no generally accepted technique for daily use.

Objective:

This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.

Safety points:

  • Clinical parameters - vomiting, diarrhoea
  • Biochemical parameters - base excess, urea levels
  • Daily gastric residual volume evaluation using ultrasound gastric antrum measurements after 24 hours of continuous enteral nutrition administration using both types of formulas;

Study population Consecutive patients with multiple trauma intubated and mechanical ventilated, admitted to the intensive care unit (ICU).

Sample size calculation Since the hypotheses of the study are exploratory, no formal sample size calculation has been performed. This prospective observational study aims to recruit>70 multiple trauma patients.

Randomization:

Simple randomization method will be used to assign subjects into two groups A and B.

Ethical considerations:

This study will be conducted in full conformity with the Declaration of Helsinki and Good Clinical Practices.

Local ethical committee approval will be asked before any patient will be included.

Considering that nutritional support has become a standard-of-care in every intensive care unit in the world, it is considered that this research is based on collecting data routinely available for every critically ill patient. Although no intervention is performed an informed consent will be provided.

Taking into account that the included patients are not able to provide informed consent at the time of recruitment (on ICU admission), a Power of Attorney or a Legal tutor will act as Consultee and will be asked to consent/decline participation to the study on legal behalf of the patient. If patients have Advance Decision Plan including participation in research studies the Plan will be respected and recruitment pursued/abandoned accordingly.

After regaining capacity, all patients will be asked to provide Informed Consent for using their personal data and will be given the possibility to:

Provide Informed Consent for the acute data and follow-up. Deny research participation and request destruction of acute data collected.

Study participant research data, which is for purposes of statistical analysis and scientific reporting, will be transmitted to the Data Manager and the Statistician of the study.

Expected impact of the study KNOWLEDGE The investigators aim to provide a detailed description of protein administration using two different types of enteral formulas. The main objectives of the study are to evaluate energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with different protein content. Nevertheless, the investigators want to provide data about the impact of these different enteral nutrition formulas on body composition as well as on functionality.

Regarding of the obtained data a change on local and national recommendation considering enteral nutrition in multiple trauma patients is to be expected.

Funding All the enteral nutrition products are donated by the Nutricia Global. No funding will be received for this study.

02

Conditions studied

  • Metabolism
  • Trauma
  • Nutritional Deficiency
  • Protein Malnutrition
  • Gastroparesis
  • Muscle Loss
  • Calorie Malnutrition Protein

Keywords

  • enteral nutrition
  • multiple trauma
  • energy target
  • protein target
  • body composition
  • gastric residual volume
  • enteral nutrition intolerance
03

In context

Multiple Trauma Reclassified

139 studies on the registry are indexed under Multiple Trauma; 32 are open to participants now.

This study's planned enrollment of 70 is below the median of 200 across 84 observational studies indexed under Multiple Trauma.

Browse Multiple Trauma studies →

Lead sponsor

Romanian Society for Enteral and Parenteral Nutrition is the lead sponsor of 3 studies on the registry; 3 are open to participants now.

Compared within Multiple Trauma, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Wounds and Injuries. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Consecutive patients with multiple trauma intubated and mechanical ventilated, admitted to the intensive care unit (ICU)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (>18 yrs) admitted to the ICU
  • Multiple trauma (Injury severity score > 18)
  • Intubation and mechanical ventilation upon admission in ICU or during the first 24 hours of admission, for at least 48 h

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years
  • Pregnant women
  • Patients not intubated or not mechanically ventilated or receiving only non-invasive ventilation
  • Patients with enteral feeding 48 h after admission
  • Patients with recent gastrointestinal surgical intervention
  • Patients on chronic therapy with
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
70 participants (estimated)
Target follow-up
8 Weeks
Patient registry
Yes

Groups and cohorts

  • Group A

    Group A - enteral formula with 6.3 g/100 ml protein

    Other: Medical food

  • Group B

    enteral formula with 10 g/100 ml protein

    Other: Medical food

Interventions

  • OtherMedical food

    enteral formulas with different protein composition

06

What researchers measure

Primary outcomes

  1. Calorie and protein target

    Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content

    Time frame: on day 5 days

  2. Calorie and protein target

    Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content

    Time frame: on day 10

Secondary outcomes

  1. Ultrasound-guided assessment of gastric residual volume

    Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content. Ultrasound assessment of gastric volume using a current model for GV assessment based on antral cross-sectional area (CSA) - GV (ml)1⁄427.0+14.6×right-lateral CSA (cm2)21.28×age (yr)

    Time frame: on day 5

  2. Ultrasound-guided assessment of gastric residual volume

    Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content. Ultrasound assessment of gastric volume using a current model for GV assessment based on antral cross-sectional area (CSA) - GV (ml)1⁄427.0+14.6×right-lateral CSA (cm2)21.28×age (yr)

    Time frame: on day 10

  3. Muscle function

    Muscle function evaluation using handgrip dynamometer after extubation and sedation cessation

    Time frame: 24 hours after extubation

  4. Muscle function

    Muscle function evaluation using handgrip dynamometer after extubation and sedation cessation

    Time frame: 5 days after extubation

  5. Body composition - Fat-free body mass

    Fat-free body mass assessment using bioelectrical impedance analysis

    Time frame: 24 hours after extubation

  6. Body composition - Fat-free body mass

    Fat-free body mass assessment using whole-body bioelectrical impedance

    Time frame: 5 days after extubation

  7. Body composition - Total body water

    Total body water assessment using whole-body bioelectrical impedance analysis

    Time frame: 24 hours after extubation

  8. Body composition - Total body water

    Total body water assessment using whole-body bioelectrical impedance analysis

    Time frame: 5 days after extubation

  9. Body composition - Phase angle

    Phase angle measurement using whole-body bioelectrical impedance analysis

    Time frame: 24 hours after extubation

  10. Body composition - Phase angle

    Phase angle measurement using whole-body bioelectrical impedance analysis

    Time frame: 5 days after extubation

  11. Body composition - ultrasound

    Quadriceps rectus femoris thickness thickness measured by B-mode ultrasonography

    Time frame: baseline (on admission/first 24 hours)

  12. Body composition - ultrasound

    Quadriceps rectus femoris thickness measured by B-mode ultrasonography

    Time frame: on day 5

  13. Body composition - ultrasound

    Quadriceps rectus femoris thickness measured by B-mode ultrasonography

    Time frame: on day 10

  14. Body composition - ultrasound

    Quadriceps rectus femoris thickness measured by B-mode ultrasonography

    Time frame: on day 15

  15. Inflammation - CRP

    Plasmatic levels of C-reactive protein

    Time frame: on day 5

  16. Inflammation - CRP

    Plasmatic levels of C-reactive protein

    Time frame: on day 10

  17. Inflammation - prealbumin

    Plasmatic levels of prealbumin

    Time frame: on day 5

  18. Inflammation - prealbumin

    Plasmatic levels of prealbumin

    Time frame: on day 10

07

Study locations

1 of 1 sites recruiting
  • Clinical Emergency Hospital of Bucharest
    Bucharest, Romania
    Recruiting
    • Ioana Grințescu, Professor · Contactioana.grintescu@rospen.ro · +40722329187
    • Cristian Cobilinschi, MD, PhD · Contactcristian.cobilinschi@umfcd.ro · +40765018776
    • Liliana Mirea, MD, PhD · Principal investigator
    • Raluca Ungureanu, MD, PhD · Principal investigator
    • Cristian Cobilinschi, MD, PhD · Principal investigator
    • Ioana Grintescu, MD, PhD · Principal investigator
    • Ana Maria Cotae, MD · Principal investigator
    • Diana Iacob, MD · Sub investigator
    • Angela Popa, MD · Sub investigator
    • Ioana Dumitru, MD · Sub investigator
    • Mihaela Buiuc, MD · Sub investigator
08

References and documents

Publications

  • van Zanten ARH, Petit L, De Waele J, Kieft H, de Wilde J, van Horssen P, Klebach M, Hofman Z. Very high intact-protein formula successfully provides protein intake according to nutritional recommendations in overweight critically ill patients: a double-blind randomized trial. Crit Care. 2018 Jun 12;22(1):156. doi: 10.1186/s13054-018-2070-5. PubMed 29895309 ↗
  • Singer P. Protein metabolism and requirements in the ICU. Clin Nutr ESPEN. 2020 Aug;38:3-8. doi: 10.1016/j.clnesp.2020.03.026. Epub 2020 May 31. PubMed 32690175 ↗
  • Tedeschi-Jockers F, Reinhold S, Hollinger A, Tuchscherer D, Kiss C, Gantner L, Ledergerber K, Zimmermann S, Scheuzger J, Huber J, Siegemund M. A new high protein-to-energy enteral formula with a whey protein hydrolysate to achieve protein targets in critically ill patients: a prospective observational tolerability study. Eur J Clin Nutr. 2022 Mar;76(3):419-427. doi: 10.1038/s41430-021-00956-9. Epub 2021 Jun 24. PubMed 34168292 ↗
  • Berger MM, Reintam-Blaser A, Calder PC, Casaer M, Hiesmayr MJ, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Bischoff SC, Singer P. Monitoring nutrition in the ICU. Clin Nutr. 2019 Apr;38(2):584-593. doi: 10.1016/j.clnu.2018.07.009. Epub 2018 Jul 20. PubMed 30077342 ↗
  • Yasuda H, Kondo N, Yamamoto R, Asami S, Abe T, Tsujimoto H, Tsujimoto Y, Kataoka Y. Monitoring of gastric residual volume during enteral nutrition. Cochrane Database Syst Rev. 2021 Sep 27;9(9):CD013335. doi: 10.1002/14651858.CD013335.pub2. PubMed 34596901 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Data requests can be submitted by researchers in the field of clinical nutrition starting 9 months after article publication and the data will be made accessible for up to 3 years. Extensions will be considered on a case-by-case basis

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: 2024 3 years

Access criteria: Interest in data analysis, appropriate background in the field

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05647135
Lead sponsor
Romanian Society for Enteral and Parenteral Nutrition
Responsible party
Sponsor
First posted
Dec 12, 2022
Start date
Mar 1, 2023
Primary completion
Dec 1, 2024 (estimated)
Completion
Dec 1, 2024 (estimated)
Last update
Jul 22, 2024

Study contacts

Ioana Grintescu, MD, PhD
Contact
ioana.grintescu@rospen.ro
+40722329187
Cristian Cobilinschi, MD, PhD
Contact
cristian.cobilinschi@umfcd.ro
+40765018776
Ioana Grintescu, MD, PhD
study director · Romanian Society of Enteral and Parenteral Nutrition

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion